Immunophotonics is an early stage biotechnology company engaged in the development of a proprietary novel drug product for use in an in situ autologous cancer vaccine (inCVAX) for the treatment of metastatic solid tumor cancers.


Publications show all

ImmunoPhotonics has published 5 articles.

Patents show all


SEC Filings show all


Contact Information

1601 South Providence Road, Suite 113
Columbia, MO 65211
United States



    Total FundingEmployeesLast Funding DateStatus

    Crunchbase Investment Rounds

    DateAmountRoundValuationLead InvestorOther Investors
    2014-07-31Series ABilliken Angels Network
    2011-05-27$100,123Series Unknown
    2010-05-12$550,000Series Unknown
    2015-01-26$1,800,000Series ACultivation CapitalMissouri Technology Corporation, St. Louis Arch Angels, BioGenerator, Billiken Angels Network, iSELECT FUND
    2014-09-03$1,800,000Series ABioGenerator, Cultivation CapitaliSELECT FUND